Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
SD Dowall, KR Buttigieg, SJD Findlay-Wilson, E Rayner, G Pearson, A Miloszewska, VA Graham, MW Carroll & R Hewson. (2016) A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Human Vaccines & Immunotherapeutics 12:2, pages 519-527.
Read now
Read now
Articles from other publishers (55)
Büşra Ahata & Günseli Bayram Akçapınar. (2023) CCHFV vaccine development, current challenges, limitations, and future directions. Frontiers in Immunology 14.
Crossref
Crossref
Joseph W. Golden, Collin J. Fitzpatrick, John J. Suschak, Tamara L. Clements, Keersten M. Ricks, Mariano Sanchez-Lockhart & Aura R. Garrison. (2023) Induced protection from a CCHFV-M DNA vaccine requires CD8+ T cells. Virus Research 334, pages 199173.
Crossref
Crossref
Sathyavathy. G. (2023) Crimean-Congo Hemorrhagic Fever (CCHF). A and V Pub International Journal of Nursing and Medical Research, pages 52-55.
Crossref
Crossref
Gang Zhang, Pu Wang, Lingling Jiang, Yunyi Kong, Sheng Wang, Yong Li & Sinong Zhang. (2023) Evaluation of the immunogenicity of a Crimean-Congo hemorrhagic fever virus vaccine candidate in mice developed based on a baculovirus Zera nanoparticle delivery system. Frontiers in Veterinary Science 10.
Crossref
Crossref
Furqan Munir, Amna Shakoor, Zia ud Din Sindhu & Muhammad Tahir Aleem. (2023) Crimean-Congo hemorrhagic fever: Immunopathogenesis and recent advances in the development of vaccines. Microbial Pathogenesis 177, pages 106054.
Crossref
Crossref
Begoña Febrer-Sendra, Pedro Fernández-Soto, Juan García-Bernalt Diego, Beatriz Crego-Vicente, Anabel Negredo, Juan Luis Muñor-Bellido, Moncef Belhassen-García, María Paz Sánchez-Seco & Antonio Muro. (2023) A Novel RT-LAMP for the Detection of Different Genotypes of Crimean–Congo Haemorrhagic Fever Virus in Patients from Spain. International Journal of Molecular Sciences 24:7, pages 6411.
Crossref
Crossref
Felicity Jane Burt & Dominique Goedhals. 2022. Zoonoses: Infections Affecting Humans and Animals. Zoonoses: Infections Affecting Humans and Animals
1
27
.
Canakoglu Nurettin, Berber Engin, Tonbak Sukru, Aktas Munir, Vatansever Zati & Ozdarendeli Aykut. (2022) The Seroprevalence of Crimean-Congo Hemorrhagic Fever in Wild and Domestic Animals: An Epidemiological Update for Domestic Animals and First Seroevidence in Wild Animals from Turkiye. Veterinary Sciences 9:9, pages 462.
Crossref
Crossref
Qi Wang, Shen Wang, Zhikang Shi, Zhengrong Li, Yongkun Zhao, Na Feng, Jinhao Bi, Cuicui Jiao, Entao Li, Tiecheng Wang, Jianzhong Wang, Hongli Jin, Pei Huang, Feihu Yan, Songtao Yang & Xianzhu Xia. (2022) GEM-PA-Based Subunit Vaccines of Crimean Congo Hemorrhagic Fever Induces Systemic Immune Responses in Mice. Viruses 14:8, pages 1664.
Crossref
Crossref
Md. Ashik Imran, Md. Rubiath Islam, Akash Saha, Shahida Ferdousee, Moshiul Alam Mishu & Ajit Ghosh. (2022) Development of Multi-epitope Based Subunit Vaccine Against Crimean-Congo Hemorrhagic Fever Virus Using Reverse Vaccinology Approach. International Journal of Peptide Research and Therapeutics 28:4.
Crossref
Crossref
Maaza Sana, Aneela Javed, Syed Babar Jamal, Muhammad Junaid & Muhammad Faheem. (2022) Development of multivalent vaccine targeting M segment of Crimean Congo Hemorrhagic Fever Virus (CCHFV) using immunoinformatic approaches. Saudi Journal of Biological Sciences 29:4, pages 2372-2388.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannLucie Fénéant*Bianca Bodmer*Thomas C. Mettenleiter, Allison Groseth & Thomas Hoenen. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
409
448
.
Thomas Tipih, Mark Heise & Felicity Jane Burt. (2021) Immunogenicity of a DNA-Based Sindbis Replicon Expressing Crimean–Congo Hemorrhagic Fever Virus Nucleoprotein. Vaccines 9:12, pages 1491.
Crossref
Crossref
L. F. Stovba, V. T. Krotkov, S. A. Melnikov, D. I. Paveliev, N. K. Chernikova & S. V. Borisevich. (2021) Using the vaccinia virus MVA strain for developing recombinant vector vaccines against current arboviral infections. Journal of microbiology, epidemiology and immunobiology 98:5, pages 579-587.
Crossref
Crossref
Vincent ObandaBernard AgwandaIsabel Blanco-Penedo, Irene Ann MwangiEdward King'oriGeorge P. Omondi, Clas AhlmMagnus Evander & Olivia Wesula Lwande. (2021) Livestock Presence Influences the Seroprevalence of Crimean Congo Hemorrhagic Fever Virus on Sympatric Wildlife in Kenya. Vector-Borne and Zoonotic Diseases 21:10, pages 809-816.
Crossref
Crossref
Engin Berber, Nurettin Çanakoğlu, Şükrü Tonbak & Aykut Ozdarendeli. (2021) Development of a protective inactivated vaccine against Crimean–Congo hemorrhagic fever infection. Heliyon 7:10, pages e08161.
Crossref
Crossref
Ergin SAHİN, Arzu ÇÖLERİ CİHAN, Touraj ALİGHOLİPOUR, Katalin FOLDES, Evren Doruk ENGİN & Aykut ÖZKUL. (2021) Assessment of the Immunogenicity and Protective Aspects of a DNA Vaccine Targeting Crimean Congo Hemorrhagic Fever Virus Glycoprotein GcKırım Kongo Kanamalı Ateşi Virüsü Glikoprotein Gc’yi Hedef Alan Bir DNA Aşısının Bağışıklık ve Koruyuculuk Sağlama Özelliklerinin Değerlendirilmesi. Düzce Tıp Fakültesi Dergisi 23:1, pages 66-75.
Crossref
Crossref
Ciaran Gilbride, Jack Saunders, Hannah Sharpe, Emmanuel Atangana Maze, Georgina Limon, Anna Barbara Ludi, Teresa Lambe & Sandra Belij-Rammerstorfer. (2021) The Integration of Human and Veterinary Studies for Better Understanding and Management of Crimean-Congo Haemorrhagic Fever. Frontiers in Immunology 12.
Crossref
Crossref
David W. Hawman, Gustaf Ahlén, K. Sofia Appelberg, Kimberly Meade-White, Patrick W. Hanley, Dana Scott, Vanessa Monteil, Stephanie Devignot, Atsushi Okumura, Friedemann Weber, Heinz Feldmann, Matti Sällberg & Ali Mirazimi. (2020) A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model. Nature Microbiology 6:2, pages 187-195.
Crossref
Crossref
Shaikh Terkis Islam Pavel, Hazel Yetiskin, Ahmet Kalkan & Aykut Ozdarendeli. (2020) Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model. PLOS Neglected Tropical Diseases 14:11, pages e0008834.
Crossref
Crossref
Teresa E. Sorvillo, Sergio E. Rodriguez, Peter Hudson, Megan Carey, Luis L. Rodriguez, Christina F. Spiropoulou, Brian H. Bird, Jessica R. Spengler & Dennis A. Bente. (2020) Towards a Sustainable One Health Approach to Crimean–Congo Hemorrhagic Fever Prevention: Focus Areas and Gaps in Knowledge. Tropical Medicine and Infectious Disease 5:3, pages 113.
Crossref
Crossref
Ashwin Ashok Raut, Pradeep N. Gandhale, D. Senthil Kumar, Naveen Kumar, Atul Pateriya, Anamika Mishra & Diwakar D. Kulkarni. 2020. Emerging and Transboundary Animal Viruses. Emerging and Transboundary Animal Viruses
255
283
.
Hassan Nasirian. (2019) Crimean-Congo hemorrhagic fever (CCHF) seroprevalence: A systematic review and meta-analysis. Acta Tropica 196, pages 102-120.
Crossref
Crossref
Garrison, Smith & Golden. (2019) Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease. Viruses 11:7, pages 590.
Crossref
Crossref
Muhammad Usman Mirza, Michiel Vanmeert, Matheus Froeyen, Amjad Ali, Shazia Rafique & Muhammad Idrees. (2019) In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors. Scientific Reports 9:1.
Crossref
Crossref
Touraj Aligholipour Farzani, Katalin Földes, Alireza Hanifehnezhad, Burcu Yener Ilce, Seval Bilge Dagalp, Neda Amirzadeh Khiabani, Koray Ergünay, Feray Alkan, Taner Karaoglu, Hurrem Bodur & Aykut Ozkul. (2019) Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models. Viruses 11:3, pages 237.
Crossref
Crossref
Masayuki Shimojima. 2019. Severe Fever with Thrombocytopenia Syndrome. Severe Fever with Thrombocytopenia Syndrome
231
246
.
David W. Hawman & Heinz Feldmann. (2018) Recent advances in understanding Crimean–Congo hemorrhagic fever virus. F1000Research 7, pages 1715.
Crossref
Crossref
Ayse S. Dereli & Veysel Kayser. (2018) Crimean–Congo Hemorrhagic Fever: A bibliometric assessment of the literature. Journal of Infection and Public Health 11:1, pages 147-148.
Crossref
Crossref
Stuart D. Dowall, Miles W. Carroll & Roger Hewson. (2017) Development of vaccines against Crimean-Congo haemorrhagic fever virus. Vaccine 35:44, pages 6015-6023.
Crossref
Crossref
Aura R. Garrison, Charles J. Shoemaker, Joseph W. Golden, Collin J. Fitzpatrick, John J. Suschak, Michelle J. Richards, Catherine V. Badger, Carolyn M. Six, Jacqueline D. Martin, Drew Hannaman, Marko Zivcec, Eric Bergeron, Jeffrey W. Koehler & Connie S. Schmaljohn. (2017) A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. PLOS Neglected Tropical Diseases 11:9, pages e0005908.
Crossref
Crossref
Jorma Hinkula, Stéphanie Devignot, Sara Åkerström, Helen Karlberg, Eva Wattrang, Sándor Bereczky, Mehrdad Mousavi-Jazi, Christian Risinger, Gunnel Lindegren, Caroline Vernersson, Janusz Paweska, Petrus Jansen van Vuren, Ola Blixt, Alejandro Brun, Friedemann Weber & Ali Mirazimi. (2017) Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice. Journal of Virology 91:10.
Crossref
Crossref
Isolde Schuster, Marc Mertens, Bernd Köllner, Tomáš Korytář, Markus Keller, Bärbel Hammerschmidt, Thomas Müller, Noël Tordo, Philippe Marianneau, Claudia Mroz, Melanie Rissmann, Eileen Stroh, Lisa Dähnert, Felicitas Hammerschmidt, Rainer G. Ulrich & Martin H. Groschup. (2016) A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies. Antiviral Research 134, pages 161-166.
Crossref
Crossref
Elitsa Panayotova, Anna Papa, Iva Trifonova & Iva Christova. (2016) Crimean-Congo hemorrhagic fever virus lineages Europe 1 and Europe 2 in Bulgarian ticks. Ticks and Tick-borne Diseases 7:5, pages 1024-1028.
Crossref
Crossref
Stuart D. Dowall, Victoria A. Graham, Emma Rayner, Laura Hunter, Robert Watson, Irene Taylor, Antony Rule, Miles W. Carroll & Roger Hewson. (2016) Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses. PLOS ONE 11:6, pages e0156637.
Crossref
Crossref
Anna Papa, Styliani Pappa, Elitsa Panayotova, Elpida Papadopoulou & Iva Christova. (2016) Molecular epidemiology of Crimean-Congo hemorrhagic fever in Bulgaria-An update. Journal of Medical Virology 88:5, pages 769-773.
Crossref
Crossref
Isolde Schuster, Marc Mertens, Slavcho Mrenoshki, Christoph Staubach, Corinna Mertens, Franziska Brüning, Kerstin Wernike, Silke Hechinger, Kristaq Berxholi, Dine Mitrov & Martin H. Groschup. (2015) Sheep and goats as indicator animals for the circulation of CCHFV in the environment. Experimental and Applied Acarology 68:3, pages 337-346.
Crossref
Crossref
Tariq A. G. Aziz, Dlovan J. Ali & Dilshad O. Jaff. (2016) Molecular and Serological Detection of Crimean-Congo Hemorrhagic Fever Virus in Sulaimani Province, Iraq. Journal of Biosciences and Medicines 04:04, pages 36-42.
Crossref
Crossref
Cong Jin & Dexin Li. 2015. Human Emerging and Re‐emerging Infections. Human Emerging and Re‐emerging Infections
43
71
.
Sara Shayan, Mohammad Bokaean, Mona Ranjvar Shahrivar & Sadegh Chinikar. (2015) Crimean-Congo Hemorrhagic Fever. Laboratory Medicine 46:3, pages 180-189.
Crossref
Crossref
Dorothea Wiemer. (2015) Der „schwarze Tod“The “Black Death”. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 58:7, pages 714-720.
Crossref
Crossref
Nurettin Canakoglu, Engin Berber, Sukru Tonbak, Mustafa Ertek, Ibrahim Sozdutmaz, Munir Aktas, Ahmet Kalkan & Aykut Ozdarendeli. (2015) Immunization of Knock-Out α/β Interferon Receptor Mice against High Lethal Dose of Crimean-Congo Hemorrhagic Fever Virus with a Cell Culture Based Vaccine. PLOS Neglected Tropical Diseases 9:3, pages e0003579.
Crossref
Crossref
Felicity Jane Burt & Dominique Goedhals. 2015. Zoonoses - Infections Affecting Humans and Animals. Zoonoses - Infections Affecting Humans and Animals
977
996
.
Jonas Klingström & Clas Ahlm. 2015. Sex and Gender Differences in Infection and Treatments for Infectious Diseases. Sex and Gender Differences in Infection and Treatments for Infectious Diseases
211
230
.
Batool Sharifi-Mood & Maliheh Metanat. (2014) Pre-Exposure and Post-Exposure Prophylaxis of Crimean-Congo Hemorrhagic Fever. Biotechnology and Health Sciences 1:2.
Crossref
Crossref
Dennis A. Bente, Naomi L. Forrester, Douglas M. Watts, Alexander J. McAuley, Chris A. Whitehouse & Mike Bray. (2013) Crimean-Congo hemorrhagic fever: History, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Research 100:1, pages 159-189.
Crossref
Crossref
Aman Kamboj & Himanshu Pathak. (2013) Crimean-Congo hemorrhagic fever: a comprehensive review. Veterinary World 6:10, pages 812-817.
Crossref
Crossref
Serkan Öncü. (2013) Crimean-Congo hemorrhagic fever: An overview. Virologica Sinica 28:4, pages 193-201.
Crossref
Crossref
Han Xia, Jiuru Zhao, Yongdong Li, Shiyu Yin, Shuang Tang, Zhong Zhang, Jingfeng Yu, Zheng Kou, Zhaojun Fan & Tianxian Li. (2013) Infection and propagation of Crimean-Congo hemorrhagic fever virus in embryonated chicken eggs. Virus Research 173:2, pages 344-349.
Crossref
Crossref
Marc Mertens, Katja Schmidt, Aykut Ozkul & Martin H. Groschup. (2013) The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Research 98:2, pages 248-260.
Crossref
Crossref
Iva Christova, Teodora Gladnishka, Evgenia Taseva, Nikolay Kalvatchev, Katerina Tsergouli & Anna Papa. (2013) Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus, Bulgaria. Emerging Infectious Diseases 19:1, pages 177-179.
Crossref
Crossref
Guey Chuen Perng & Marylou V. Solbrig. 2013. Viral Infections of the Human Nervous System. Viral Infections of the Human Nervous System
337
368
.
Mehrdad Mousavi-Jazi, Helen Karlberg, Anna Papa, Iva Christova & Ali Mirazimi. (2012) Healthy individuals’ immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. Vaccine 30:44, pages 6225-6229.
Crossref
Crossref
Atila T. Kalaycioglu, Riza Durmaz, Yavuz Uyar, Ozlem Unaldi, Ertugrul Aksekili, Aykut Ozkul, Gulay Korukluoglu & Mustafa Ertek. (2012) Lack of genetic diversity in Crimean‐Congo hemorrhagic fever viruses in Turkey: Assessment of present and future patterns of disease. Journal of Medical Virology 84:3, pages 471-478.
Crossref
Crossref
Helena C Maltezou & Anna Papa. (2011) Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment. BMC Medicine 9:1.
Crossref
Crossref